About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Metamizole
- Procedure number
- PSUSA/00001997/202003
- Regulatory outcome
- Variation
Documents
Metamizole: List of nationally authorised medicinal products - PSUSA/00001997/202003
English (EN) (162.1 KB - PDF)
Metamizole: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001997/202003
English (EN) (153.93 KB - PDF)
български (BG) (199.2 KB - PDF)
español (ES) (56.59 KB - PDF)
čeština (CS) (186.62 KB - PDF)
dansk (DA) (158.48 KB - PDF)
Deutsch (DE) (232.71 KB - PDF)
eesti keel (ET) (157.86 KB - PDF)
ελληνικά (EL) (176.46 KB - PDF)
français (FR) (175.53 KB - PDF)
hrvatski (HR) (176.96 KB - PDF)
italiano (IT) (231.39 KB - PDF)
latviešu valoda (LV) (187.47 KB - PDF)
lietuvių kalba (LT) (192.47 KB - PDF)
magyar (HU) (64.54 KB - PDF)
Malti (MT) (190.82 KB - PDF)
Nederlands (NL) (115.56 KB - PDF)
polski (PL) (192.48 KB - PDF)
português (PT) (159.83 KB - PDF)
română (RO) (163.62 KB - PDF)
slovenčina (SK) (215.8 KB - PDF)
slovenščina (SL) (182.66 KB - PDF)
Suomi (FI) (157.08 KB - PDF)
svenska (SV) (158.64 KB - PDF)